R-flurbiprofen Improves Learning in Alzheimer's Mice
Author Information
Author(s): Kukar Thomas, Prescott Sonya, Eriksen Jason L, Holloway Vallie, Murphy M Paul, Koo Edward H, Golde Todd E, Nicolle Michelle M
Primary Institution: Mayo Clinic College of Medicine
Hypothesis
Chronic administration of R-flurbiprofen will improve cognitive function and reduce Aβ levels in Tg2576 APP mice.
Conclusion
Chronic administration of R-flurbiprofen can improve spatial learning deficits if given before plaque deposition in Tg2576 mice.
Supporting Evidence
- R-flurbiprofen improved spatial learning in the Morris water maze.
- Treatment before plaque deposition was crucial for cognitive improvement.
- A modest reduction in Aβ levels was observed but not statistically significant.
- Older mice treated for two weeks did not show cognitive improvement.
- R-flurbiprofen was well-tolerated at the administered dose.
Takeaway
Giving a special medicine called R-flurbiprofen to mice before they get sick helps them learn better.
Methodology
Young Tg2576 mice were given R-flurbiprofen for four months to assess its effects on learning and Aβ levels.
Potential Biases
Potential bias due to the small sample size and the specific mouse model used.
Limitations
The study used a sub-optimal dose of R-flurbiprofen due to toxicity at higher doses.
Participant Demographics
Transgenic Tg2576 APP mice, both young and older.
Statistical Information
P-Value
p < 0.0001
Statistical Significance
p < 0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website